Contact Us Suppport HCC Webmail
ADVERTISEMENT

Custom Search
Today's Health Headlines
WASHINGTON (Reuters) - Twenty-two million Americans would lose insurance over the next decade under the U.S. Senate Republican healthcare bill, a nonpartisan congressional office said on Monday, complicating the path forward for the already-fraught legislation.

(Reuters) - Glyphosate, an herbicide and the active ingredient in Monsanto Co's popular Roundup weed killer, will be added to California's list of chemicals known to cause cancer effective July 7, the state's Office of Environmental Health Hazard Assessment (OEHHA) said on Monday.

CHICAGO (Reuters) - A U.S. judge should order Illinois to pay Medicaid providers about $1 billion a month to ensure medical care continues for the three million recipients of the health program after talks with the state reached an impasse, according to a court filing on Monday.

CHICAGO (Reuters) - A study testing the value of DNA sequencing as part of routine medical care showed that roughly one in five people carried a mutation linked with rare disease, but few actually benefited from that information, researchers reported on Monday.

ZURICH (Reuters) - Roche said a new Esbriet tablet formulation was approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF), a fatal condition that causes irreversible, progressive scarring of the lungs.

ZURICH (Reuters) - Novartis's generics unit Sandoz said the European Commission approved Erelzi, its biosimilar to Amgen's Enbrel, to treat inflammatory diseases such as rheumatoid arthritis, psoriasis, and psoriatic arthritis.

WASHINGTON (Reuters) - Twenty-two million Americans would lose their health insurance coverage over the next decade under draft legislation unveiled by Senate Republicans last week, the non-partisan Congressional Budget Office said on Monday.

(Reuters Health) - - Health insurance saves lives – that’s the conclusion of a report released on Monday, just in time to weigh into the debate among Senate Republicans considering a bill that could strip millions of Americans of coverage.

NEW YORK (Reuters) - Martin Shkreli, the pharmaceutical entrepreneur vilified as the "pharma bro" for raising the price of a life-saving drug by 5,000 percent, will go on trial on Monday for what U.S. prosecutors called a Ponzi-like scheme at his former hedge fund and a drug company he once ran.

BOSTON (Reuters) - A former Massachusetts pharmacy executive was sentenced to nine years in prison on Monday after being convicted of racketeering and fraud charges for his role in a deadly U.S. meningitis outbreak in 2012.

Welcome Guest
Username: 
Password:
Not a member? Sign Up!
Browse RSS Feeds
click here when finished
Save Page Layout
Video
loading